https://sermonixpharma.com/wp-content/uploads/2019/12/cropped-sermonix.jpg
cropped-sermonix.jpg
Recent Posts
- Sermonix Pharmaceuticals Announces MBC Alliance Membership, New ‘Discover ELAINE’ Website
- Henlius and Sermonix Announce Strategic Collaboration and Exclusive License Agreements for Novel Endocrine Therapy Lasofoxifene
- Sermonix Pharmaceuticals Shares Results of Third Survey on ESR1 and Metastatic Breast Cancer Patient Quality of Life
- Sermonix Pharmaceuticals Shares Pharmacokinetic and Baseline Genomic Clinical Data Tied to ELAINE Lasofoxifene Trials of Patients With ESR1 Mutations
- Sermonix Pharmaceuticals Announces Publication of ELAINE-1 and ELAINE-2 Trial Results in Annals of Oncology
Archives
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- June 2023
- May 2023
- March 2023
- February 2023
- December 2022
- November 2022
- September 2022
- August 2022
- June 2022
- April 2022
- February 2022
- December 2021
- November 2021
- June 2021
- May 2021
- April 2021
- January 2021
- December 2020
- October 2020
- September 2020
- July 2020
- June 2020
- December 2019
- September 2019
- June 2019
- May 2019
- April 2019
- March 2019
Recent Comments